Rewalk Robotics Ltd. (RWLK): Wayne Weisman , director 10% owner of Rewalk Robotics Ltd. sold 16,148 shares on May 19, 2016. The Insider selling transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were sold at $9.10 per share for a total value of $146,805.47 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 23, 2016, Jeff Dykan (director 10% owner) sold 16,148 shares at $9.10 per share price.On Mar 9, 2016, Wayne Weisman (director 10% owner) sold 3,002 shares at $8.33 per share price.
Shares of Rewalk Robotics Ltd (RWLK) ended Friday, May 20, 2016 session in red amid volatile trading. The shares closed down -0.25 points or -2.73% at $8.92 with 62,988 shares getting traded. Post opening the session at $9.15, the shares hit an intraday low of $8.92 and an intraday high of $9.35 and the price vacillated in this range throughout the day. The company has a market cap of $110,349 M and the number of outstanding shares has been calculated to be 12,37,10,00,000 shares. The 52-week high of Rewalk Robotics Ltd is $17.4 and the 52-week low is $5.55.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing to commercialize ReWalk an exoskeleton that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk is a product that can fundamentally change the health and life experiences of users. ReWalk controls movement using subtle changes in the users center of gravity.